Nalmefene update

Drug: Nalmefene


The Trust Drug and Therapeutics Committee has approved the use of nalmefene (Selincro) for the reduction of alcohol consumption in adult patients who have a high drinking risk level.  The prescribing of nalmefene is restricted to Addictions consultants only. 

(D&TC – 17/10/2013)

Date: 20 November 2013.

Website Design by ConsultSMB